www.bloomberg.com
Open in
urlscan Pro
151.101.129.73
Public Scan
Submitted URL: http://go.pardot.com/e/710433/positive-covid-vaccine-results/dwtqd/505894619?h=xQ0ERcB-PPuEhcZQKw1EO9ptyJDJKBaTuTm-MC...
Effective URL: https://www.bloomberg.com/news/articles/2022-04-29/glaxo-and-sk-bioscience-report-positive-covid-vaccine-results
Submission: On May 02 via api from US — Scanned from DE
Effective URL: https://www.bloomberg.com/news/articles/2022-04-29/glaxo-and-sk-bioscience-report-positive-covid-vaccine-results
Submission: On May 02 via api from US — Scanned from DE
Form analysis
0 forms found in the DOMText Content
Skip to content Skip to content Bloomberg the Company & Its ProductsThe Company & its ProductsBloomberg Terminal Demo RequestBloomberg Anywhere Remote LoginBloomberg Anywhere LoginBloomberg Customer SupportCustomer Support Bloomberg Webinars: Access a broad range of analysis, research, insight & ideas. BLOOMBERG Europe Edition * Europe * U.S. * Asia * Middle East * Africa * 日本 Sign In Sign Out Subscribe * Live Now BLOOMBERG TV+ BLOOMBERG THE OPEN Jonathan Ferro drives you through the market moving events from around the world on Bloomberg's The Open. 60 minutes featuring the brightest minds on Wall Street, taking you through the most important hour of the trading day. BLOOMBERG RADIO BLOOMBERG SURVEILLANCE The economy and markets are "under surveillance". Bloomberg Surveillance, covering the latest news in finance, economics and investments. Listen -------------------------------------------------------------------------------- QUICKTAKE CITYLAB In 2018, Paradise, California, lost over 80 percent of its homes to the Camp Fire. Now local leaders are proposing an ambitious scheme to protect the town from future blazes. ALSO STREAMING ON YOUR TV: * * Markets Markets * Economics * Deals * Odd Lots * The FIX | Fixed Income * ETFs * FX * Factor Investing * Alternative Investing * Economic Calendar * Markets Magazine HYPERDRIVE German Used-Car Prices Hit Record on Tight Supply Chains PROGNOSIS Vertex Falls After FDA Halts Diabetes Study in Surprise Move MARKET DATA * Stocks * Commodities * Rates & Bonds * Currencies * Futures * Sectors FOLLOW BLOOMBERG MARKETS View More Markets * Technology Technology * Work Shifting * Code Wars * Checkout * Prognosis TECHNOLOGY Google Spinoff Sandbox AQ Gets Backing from CIA’s Venture Arm HYPERDRIVE Tesla Delays Filing as Investors Await Word on Possible Stock Split TECHNOLOGY Apple Hit With EU Antitrust Complaint Over iPhone Payments FOLLOW BLOOMBERG TECHNOLOGY View More Technology * Politics Politics * US * UK * Americas * Europe * Asia * Middle East POLITICS GOP Loses Bid to Block Jan. 6 Committee’s Demand for Email Data POLITICS Spanish Premier’s Phone Was Hacked With Spy Software in 2021 FEATURED * Next China FOLLOW BLOOMBERG POLITICS View More Politics * Wealth Wealth * Investing * Living * Opinion & Advice * Savings & Retirement * Taxes * Reinvention SAVINGS & RETIREMENT ‘I Put Faith in These Guys’: Vanguard Clients Decry Tax Debacle INVESTING Milken Unmasked: Frivolity and Fear as Elite Descend on LA FEATURED * How to Invest FOLLOW BLOOMBERG WEALTH View More Wealth * Pursuits Pursuits * Travel * Autos * Homes * Living * Culture * Style PURSUITS New Met Exhibit Examines American Fashion, Frame By Frame HYPERDRIVE Porsche Nears Agreement to Join Formula 1, VW CEO Says FEATURED * Screentime * New York Property Prices * Where to Go in 2022 FOLLOW BLOOMBERG PURSUITS View More Pursuits * Opinion Opinion * Business * Finance * Economics * Markets * Politics & Policy * Technology & Ideas * Editorials * Letters EMILY OSTER How It Became Taboo to Tell Your Kid ‘Good Job’ THE EDITORS How to Make the CDC Matter Again LISA JARVIS Better Vaccines Are in Sight — for the Next Pandemic FOLLOW BLOOMBERG OPINION View More Opinion * Businessweek Businessweek * The Bloomberg 50 * Best B-Schools * Small Business Survival Guide * 50 Companies to Watch * Good Business * Subscribe to the Magazine TECHNOLOGY Nobody Knows Where the Red Line Is for Cyberwarfare FINANCE ESG Investing Is Hard. Doing It via ETFs Is Harder REMARKS Jack Bogle Was a Punk FOLLOW BLOOMBERG BUSINESSWEEK View More Businessweek * Equality Equality * Corporate Leadership * Capital * Society * Solutions SOCIETY Taylor Edges Serrano at MSG, Stays Women’s Lightweight Champ EQUALITY Lyft Takes Stance Against Oklahoma, Texas Abortion Restrictions EQUALITY MLB Suspends Dodgers Pitcher Bauer for Two Seasons Over Alleged Sex Assault FOLLOW BLOOMBERG EQUALITY View More Equality * Green Green * Science & Energy * Climate Adaptation * Finance * Politics * Culture & Design POLITICS Rich Nations Scramble to Seal Coal Transition Deals Before COP27 CLIMATE ADAPTATION U.K. Set to Be Hotter Than Ibiza This Week With Temperatures Reaching 21°C FEATURED * Data Dash * Hyperdrive FOLLOW BLOOMBERG GREEN View More Green * CityLab CityLab * Design * Culture * Transportation * Economy * Environment * Housing * Justice * Government * Technology CULTURE After Immersive Van Gogh, It’s Time for Live-Cosplay ‘Bridgerton’ TRANSPORTATION Hong Kong’s Star Ferry Needs a Rescue Plan With No Tourists in Sight HOUSING Desperate for Housing, Austin Seeks Relief in Rezoning FOLLOW BLOOMBERG CITYLAB View More CityLab * Crypto Crypto * Decentralized Finance * NFTs * Regulation * Technology CRYPTO Solana Suffers Seven-Hour Outage as NFT Demand Spills Over CRYPTO Crypto Hackers Swipe $77 Million in Attack on DeFi Projects CRYPTO Crypto Brokerage Genesis First-Quarter Lending Falls as Market Weakens FOLLOW BLOOMBERG CRYPTO View More Crypto * More -------------------------------------------------------------------------------- Markets GLAXO AND SK BIOSCIENCE REPORT POSITIVE COVID VACCINE RESULTS By James Paton +Follow April 29, 2022, 8:10 AM GMT LISTEN TO THIS ARTICLE :51 SHARE THIS ARTICLE Copied Follow the authors @JamesPaton14 + Get alerts forJames Paton GlaxoSmithKline Plc and SK Bioscience Co. said they’re seeking authorization for their Covid vaccine in South Korea after positive results in a late-stage study. The companies said Friday the shot met its objectives in the trial and an agreement has been signed with Korean authorities to supply 10 million doses. SK Bioscience conducted a trial in 4,037 adults across six countries and said it found that the vaccine candidate demonstrated superior results compared with AstraZeneca Plc’s Vaxzevria. “As the Covid-19 pandemic continues to evolve, a variety of vaccines will be needed to meet the health needs across the globe,” Roger Connor, president of GSK’s vaccines business, wrote in a statement. Glaxo is also developing a separate Covid vaccine with French drugmaker Sanofi. SHARE THIS ARTICLE Copied Follow the authors @JamesPaton14 + Get alerts forJames Paton Have a confidential tip for our reporters? Get in touch Before it's here, it's on the Bloomberg Terminal Learn more LIVE ON BLOOMBERG Watch Live TVListen to Live Radio Video Player is loading. Play Video Play Unmute Current Time 0:00 / Duration 0:00 Loaded: 0% 0:00 Progress: 0% Stream Type LIVE Remaining Time -0:00 Playback Rate 1x Chapters * Chapters Captions * captions settings, opens captions settings dialog * captions off, selected Fullscreen This is a modal window. Beginning of dialog window. Escape will cancel and close the window. TextColorWhiteBlackRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentBackgroundColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentTransparentWindowColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyTransparentSemi-TransparentOpaque Font Size50%75%100%125%150%175%200%300%400%Text Edge StyleNoneRaisedDepressedUniformDropshadowFont FamilyProportional Sans-SerifMonospace Sans-SerifProportional SerifMonospace SerifCasualScriptSmall Caps Reset restore all settings to the default valuesDone Close Modal Dialog End of dialog window. Play Again Terms of Service Manage Cookies Trademarks Privacy Policy ©2022 Bloomberg L.P. All Rights Reserved Careers Made in NYC Advertise Ad Choices Help You've reached your free article limit. Explore Offerscontinue